Bayer continues positive business development
The Bayer Group was again successful in the second quarter of 2014. "Our Life Science businesses, in particular, saw unabated growth momentum, with very encouraging sales gains for our recently launched pharmaceutical products and our North and Latin American CropScience business," said Man ... more
Dieter Weinand to become President of Bayer HealthCare Pharmaceuticals
Dieter Weinand (53), President Global Commercialization & Portfolio Management at Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA, will become President of Bayer HealthCare Pharmaceuticals effective August 1, 2014 and at the same time join the Executive Commit ... more
Contract for CEO Dr. Marijn Dekkers extended to the end of 2016
At its meeting, the Supervisory Board of Bayer AG took a number of decisions pertaining to the future composition of the company’s Board of Management.
In line with his own wishes, the contract of Dr. Marijn Dekkers will be extended by just two years on expiration of the initial five-year p ... more